La cadena de opciones muestra datos clave de las opciones de acciones de Sapiens Intl Corp a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Sapiens Intl Corp..

Sapiens Intl Corp (NASDAQ:SPNS) Bolsa, Cadena de Opciones

Sapiens Intl Corp

Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.

Sapiens International Corporation N.V. - Common Shares

Sapiens International Corp NV

Barclays analyst Tavy Rosner maintains Sapiens Intl Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPNS#NASDAQ">SPNS</a>) with a Underweight and lowers the price target from $38 to $30.

News

Price Target

Analyst Ratings

SPNS

Barclays Maintains Underweight on Sapiens Intl Corp, Lowers Price Target to $30

Needham analyst Mayank Tandon maintains Sapiens Intl Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPNS#NASDAQ">SPNS</a>) with a Buy and lowers the price target from $44 to $35.

Needham Maintains Buy on Sapiens Intl Corp, Lowers Price Target to $35

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling more than 50 points on Monday.
The Dow traded up 0.76% to 44,324.99 while the NASDAQ fell 0.15% to 19,257.81. The S&amp;P 500 also rose, gaining, 0.04% to 5,998.191.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/short-ideas/24/11/41874548/top-4-health-care-stocks-that-may-plunge-this-quarter">Top 4 Health Care Stocks That May Plunge This Quarter</a>
Leading and Lagging Sectors Financials shares surged by 1.4% on Monday.
In trading on Monday, information technology shares fell by 1.3%.
Top Headline
Aramark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARMK#NYSE">ARMK</a>) reported better-than-expected fourth-quarter financial results and announced a $500 million share repurchase program. Also, the company approved a 11% increase to its quarterly dividend.
Revenue grew 5% year-over-year (Organic revenue: +7%) to $4.42 billion, missing the consensus of $4.46 billion. Adjusted EPS of 54 cents exceeded the consensus of 53 cents.
Aramark's Board of Directors approved an 11% increase in the quarterly dividend, raising it to 10.5 cents per share. The dividend will be payable on December 12, 2024, to stockholders of record as of December 2, 2024
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>CERo Therapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERO#NASDAQ">CERO</a>) shares shot up 122% to $0.1552 after the company announced the presentation of preclinical data demonstrating the capability of CER-1236 to kill ovarian cancer cells in preclinical models</li>
<li>Shares of Canaan Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAN#NASDAQ">CAN</a>) got a boost, surging 34% to $1.6915 after Bitcoin rose above $82,000.</li>
<li>MARA Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) shares were also up, gaining 25% to $23.96 amid strength in Bitcoin.</li>
</ul>
Equities Trading DOWN
<ul>
<li>1847 Holdings LLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFSH#NYSE">EFSH</a>) shares dropped 40% to $2.1600. 1847 Holdings signed a definitive agreement to acquire a cabinet, door &amp; millwork manufacturer for $18.75 million.</li>
<li>Shares of RAPT Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPT#NASDAQ">RAPT</a>) were down 44% to $1.6250 after the company terminated its Zelnecirnon program following an FDA clinical hold due to a severe adverse event involving liver injury.</li>
<li>Sapiens International Corporation N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPNS#NASDAQ">SPNS</a>) was down, falling 26% to $29.25 after the company reported worse-than-expected third-quarter EPS and sales and lowered its FY24 revenue guidance.</li>
</ul>
Commodities In commodity news, oil traded down 3.1% to $68.18 while gold traded down 2.8% at $2,619.40.
Silver traded down 2.6% to $30.620 on Monday, while copper fell 1.8% to $4.2270.
Euro zone
European shares closed higher today. The eurozone's STOXX 600 gained 1.13%, Germany's DAX gained 1.21% and France's CAC 40 gained 1.20%. Spain's IBEX 35 Index rose 0.40%, while London's FTSE 100 rose 0.65%.
The BNP Paribas Real Estate Construction PMI in Ireland rose to 49.4 in October versus 49.0 in September,
Asia Pacific Markets
Asian markets closed mostly higher on Monday, with Japan's Nikkei 225 gaining 0.08%, Hong Kong's Hang Seng Index falling 1.45%, China's Shanghai Composite Index gaining 0.51% and India's BSE Sensex gaining 0.01%.
China's annual inflation rate was 0.3% in October compared to September's reading of 0.4%, while producer prices declined by 2.9% year-over-year in October. China&#8217;s vehicle sales climbed by 7% year-over-year to 3.05 million units in October compared to a 1.7% decline in the prior month.
The gauge for Japan's service sector fell to 47.5 in October compared to a revised reading of 47.8 in the prior month, while Japan's current account surplus fell to JPY 1,717.1 billion in September from JPY 2,954.2 billion in the year-ago month.
Economics
No major economic reports are scheduled for released today.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/41871434/aramark-live-nation-entertainment-and-3-stocks-to-watch-heading-into-monday">Aramark, Live Nation Entertainment And 3 Stocks To Watch Heading Into Monday</a></li>
</ul>

Earnings

Equities

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

ARMK

CERO

EFSH

MARA

RAPT

Crude Oil Down 3%; Aramark Posts Upbeat Earnings

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling more than 50 points on Monday.
The Dow traded up 0.69% to 44,294.18 while the NASDAQ fell 0.36% to 19,217.22. The S&amp;P 500 also fell, dropping, 0.04% to 5,993.15.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/short-ideas/24/11/41874548/top-4-health-care-stocks-that-may-plunge-this-quarter">Top 4 Health Care Stocks That May Plunge This Quarter</a>
Leading and Lagging Sectors Financials shares surged by 1.5% on Monday.
In trading on Monday, information technology shares fell by 1.4%.
Top Headline
Shares of Monday.com Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) fell around 16% on Monday after the company reported results for its third quarter.
The company reported fiscal third-quarter 2024 revenue growth of 33% Y/Y to $251.0 million, beating the analyst consensus estimate of $246.1 million. The project management software company&#8217;s adjusted EPS of 85 cents beat the analyst consensus estimate of 63 cents.
Monday.com raised 2024 revenue guidance to $964 million–$966 million (prior $956 million–$961 million) against the consensus of $960.2 million and an adjusted operating margin of 12%–13% (prior 10%-11%)
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>CERo Therapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERO#NASDAQ">CERO</a>) shares shot up 155% to $0.1770 after the company announced the presentation of preclinical data demonstrating the capability of CER-1236 to kill ovarian cancer cells in preclinical models</li>
<li>Shares of Canaan Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAN#NASDAQ">CAN</a>) got a boost, surging 35% to $1.7013 after Bitcoin rose above $82,000.</li>
<li>MARA Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) shares were also up, gaining 25% to $24.06 amid strength in Bitcoin.</li>
</ul>
Equities Trading DOWN
<ul>
<li>1847 Holdings LLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFSH#NYSE">EFSH</a>) shares dropped 38% to $2.2550. 1847 Holdings signed a definitive agreement to acquire a cabinet, door &amp; millwork manufacturer for $18.75 million.</li>
<li>Shares of RAPT Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPT#NASDAQ">RAPT</a>) were down 45% to $1.5994 after the company terminated its Zelnecirnon program following an FDA clinical hold due to a severe adverse event involving liver injury.</li>
<li>Sapiens International Corporation N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPNS#NASDAQ">SPNS</a>) was down, falling 26% to $29.13 after the company reported worse-than-expected third-quarter EPS and sales and lowered its FY24 revenue guidance.</li>
</ul>
Commodities In commodity news, oil traded down 3.2% to $68.10 while gold traded down 2.7% at $2,621.70.
Silver traded down 2.8% to $30.570 on Monday, while copper fell 1.3% to $4.2495.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 1.14%, Germany's DAX gained 1.28% and France's CAC 40 gained 1.16%. Spain's IBEX 35 Index rose 0.42%, while London's FTSE 100 rose 0.61%.
The BNP Paribas Real Estate Construction PMI in Ireland rose to 49.4 in October versus 49.0 in September,
Asia Pacific Markets
Asian markets closed mostly higher on Monday, with Japan's Nikkei 225 gaining 0.08%, Hong Kong's Hang Seng Index falling 1.45%, China's Shanghai Composite Index gaining 0.51% and India's BSE Sensex gaining 0.01%.
China's annual inflation rate was 0.3% in October compared to September's reading of 0.4%, while producer prices declined by 2.9% year-over-year in October. China&#8217;s vehicle sales climbed by 7% year-over-year to 3.05 million units in October compared to a 1.7% decline in the prior month.
The gauge for Japan's service sector fell to 47.5 in October compared to a revised reading of 47.8 in the prior month, while Japan's current account surplus fell to JPY 1,717.1 billion in September from JPY 2,954.2 billion in the year-ago month.
Economics
No major economic reports are scheduled for released today.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/41871434/aramark-live-nation-entertainment-and-3-stocks-to-watch-heading-into-monday">Aramark, Live Nation Entertainment And 3 Stocks To Watch Heading Into Monday</a></li>
</ul>

MNDY

Nasdaq Moves Lower; Canaan Shares Surge

Sapiens International Corporation N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPNS#NASDAQ">SPNS</a>) shares are trading lower after the company <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n41874009/sapiens-reports-third-quarter-2024-financial-results" rel="noreferrer noopener">reported third-quarter results</a>.
Revenue rose 4.8% year over year to $137.0 million, missing the consensus of $140.07 million. Revenue growth was led by 7.1% growth in our European region, 1.7% growth in North America and 6.6% growth in ROW regions.
Adjusted operating income grew 4.3% to $25.1 million, with margin contraction of 10 bps to 18.3%. Adjusted EPS of $0.37 came <a href="https://www.benzinga.com/earnings" target="_blank" rel="noreferrer noopener">below the consensus of $0.38</a>.
Roni Al-Dor, President and CEO of Sapiens, stated,&nbsp;&#8220;Revenue fell short of our targets in the third quarter, and the challenges we encountered are expected to impact revenue in the fourth quarter.&#8221;
As of September 30, cash and cash equivalent stood at $185.95 million.
Outlook: The company adjusted 2024 non-GAAP revenue guidance to $541 million – $546 million (vs. consensus of $552.69 million), down 1.6% at the midpoint from the previous <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">$550 million – $555 million range</a>.
However, Sapiens expects non-GAAP operating margin to be within its guidance&nbsp;range at 18.2% (prior view: 18.1% &#8211; 18.5%).
For 2025, the company projects low single-digit revenue growth.
Price Action: SPNS shares are down 26% at $29.19 at the last check Monday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/41878981" target="_blank" rel="noreferrer noopener">MicroStrategy Acquires Another 27,200 Bitcoin Worth $2 Billion</a></li>
</ul>

Guidance

Small Cap

Movers

Sapiens Shares Tumble On Q3 Miss: Adjusts Outlook Amid Revenue Shortfalls

U.S. stock futures were higher this morning, with the Dow futures gaining around 150 points on Monday.
Shares of Sapiens International Corporation N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPNS#NASDAQ">SPNS</a>) fell sharply in today's pre-market trading after the company reported worse-than-expected <a href="https://www.benzinga.com/quote/SPNS/earnings">third-quarter financial results</a>.
Sapiens Intl posted third-quarter adjusted earnings of 37 cents per share, missing market estimates of 38 cents per share. The company's quarterly sales came in at $137.03 million versus expectations of $140.07 million.
Sapiens International shares dipped 21.5% to $30.98 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Sky Harbour Group Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYH#NASDAQ">SKYH</a>) shares fell 9% to $10.55 in pre-market trading. Sky Harbour will report its third-quarter financial results on Tuesday, Nov. 12.</li>
<li>NuScale Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) shares dipped 5.7% to $23.05 in pre-market trading after gaining 13% on Friday.</li>
<li>Tempus AI, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) fell 5.2% to $69.85 in pre-market trading after jumping 30% on Friday.</li>
<li>Xeris Biopharma Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XERS#NASDAQ">XERS</a>) dipped 4.9% to $3.30 in pre-market trading. Xeris Biopharma Holdings posted upbeat quarterly results on Friday.</li>
<li>Gold Fields Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GFI#NYSE">GFI</a>) declined 4.7% to $15.06 in pre-market trading.</li>
<li>Lifeway Foods, Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>) declined 4.2% to $22.10 in pre-market trading after falling 8% on Friday.</li>
<li>Butterfly Network, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFLY#NYSE">BFLY</a>) fell 3.4% to $2.53 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/41871463/dow-sp-500-notch-best-week-of-year-as-tesla-surges-post-trump-win-investor-sentiment-improves-fear-greed-index-remains-in-neutral-zone">Dow, S&amp;P 500 Notch Best Week Of Year As Tesla Surges Post Trump Win: Investor Sentiment Improves, Fear &amp; Greed Index Remains In &#8216;Neutral&#8217; Zone</a></li>
</ul>

Pre-Market Outlook

BFLY

LWAY

SKYH

XERS

Sapiens International Posts Downbeat Results, Joins Sky Harbour And Other Big Stocks Moving Lower In Monday's Pre-Market Session

WIIM

Sapiens International shares are trading lower after the company reported worse-than-expected Q3 EPS and sales and lowered its FY24 revenue guidance.

Roni Al-Dor, President and CEO of Sapiens, stated,&nbsp;"This quarter showcased solid performance in our key regions. We are pleased to report that revenue reached $137 million this quarter, reflecting a 4.8% increase over the same period last year. Revenue growth was driven by 7.1% growth in our European region, 1.7% growth in North America and 6.6% growth in ROW regions. This quarter's non-GAAP operating profit totaled $25 million, representing 18.3% of total revenue."&nbsp;
Mr. Al-Dor continued, "Revenue fell short of our targets in the third quarter, and the challenges we encountered are expected to impact revenue in the fourth quarter. Today, we are revising our 2024 non-GAAP revenue guidance to a range of $541 million to $546 million, down from the previous range of $550 million to $555 million - a 1.6% reduction at the midpoint. However, we expect our non-GAAP operating margin to be within our guidance range at 18.2%. Looking into 2025, we anticipate a low single-digit revenue growth."&nbsp;

Sapiens International Reiterated FY24 Adj Revenue Of $541M-$546M (Prior $550M-$555M) Vs $552.69M Est

Sapiens Intl Corp Q3 Adj EPS $0.37 Misses $0.38 Estimate, Sales $137.03M Miss $140.07M Estimate

<h3>Companies Reporting Before The Bell</h3>
• Global Ship Lease (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSL#NYSE">GSL</a>) is projected to report quarterly earnings at $2.41 per share on revenue of $174.31 million. 
• Monday.Com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) is projected to report quarterly earnings at $0.63 per share on revenue of $246.09 million. 
• Aramark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARMK#NYSE">ARMK</a>) is likely to report quarterly earnings at $0.53 per share on revenue of $4.46 billion. 
• ICL Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) is expected to report quarterly earnings at $0.09 per share on revenue of $2.03 billion. 
• Lincoln Educational Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINC#NASDAQ">LINC</a>) is projected to report quarterly earnings at $0.09 per share on revenue of $110.77 million. 
• Strawberry Fields REIT (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/STRW#AMEX">STRW</a>) is estimated to report earnings for its third quarter. 
• Sapiens Intl Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPNS#NASDAQ">SPNS</a>) is projected to report quarterly earnings at $0.38 per share on revenue of $140.07 million. 
• Nuwellis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) is projected to report quarterly loss at $1.28 per share on revenue of $2.36 million. 
• GEO Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) is estimated to report earnings for its third quarter. 
<h3>Companies Reporting After The Bell</h3>
• Grab Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAB#NASDAQ">GRAB</a>) is expected to report quarterly loss at $0.01 per share on revenue of $691.80 million. 
• Ispire Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPR#NASDAQ">ISPR</a>) is estimated to report quarterly loss at $0.05 per share on revenue of $52.81 million. 
• Talos Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TALO#NYSE">TALO</a>) is estimated to report quarterly loss at $0.05 per share on revenue of $500.03 million. 
• Team (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TISI#NYSE">TISI</a>) is estimated to report earnings for its third quarter. 
• Mineralys Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLYS#NASDAQ">MLYS</a>) is expected to report earnings for its third quarter. 
• Live Nation Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYV#NYSE">LYV</a>) is likely to report quarterly earnings at $1.71 per share on revenue of $8.09 billion. 
• Gatos Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GATO#NYSE">GATO</a>) is projected to report earnings for its third quarter. 
• Yalla Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YALA#NYSE">YALA</a>) is likely to report earnings for its third quarter. 
• Archrock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AROC#NYSE">AROC</a>) is estimated to report quarterly earnings at $0.27 per share on revenue of $283.55 million. 
• Ampco-Pittsburgh (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AP#NYSE">AP</a>) is likely to report earnings for its third quarter. 
• FGI Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGI#NASDAQ">FGI</a>) is estimated to report quarterly earnings at $0.03 per share on revenue of $30.69 million. 
• Bioceres Crop Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOX#NASDAQ">BIOX</a>) is expected to report quarterly earnings at $0.09 per share on revenue of $120.80 million. 
• RMR Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMR#NASDAQ">RMR</a>) is estimated to report quarterly earnings at $0.38 per share on revenue of $220.35 million. 
• Assertio Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASRT#NASDAQ">ASRT</a>) is estimated to report quarterly loss at $0.04 per share on revenue of $28.87 million. 
• Beyond Air (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAIR#NASDAQ">XAIR</a>) is projected to report quarterly loss at $0.28 per share on revenue of $1.04 million. 
• Bridger Aerospace Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAER#NASDAQ">BAER</a>) is estimated to report quarterly earnings at $0.46 per share on revenue of $57.50 million. 
• Aterian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATER#NASDAQ">ATER</a>) is expected to report quarterly loss at $0.55 per share on revenue of $26.01 million. 
• QuickLogic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUIK#NASDAQ">QUIK</a>) is likely to report quarterly loss at $0.05 per share on revenue of $4.20 million. 
• VAALCO Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EGY#NYSE">EGY</a>) is estimated to report quarterly earnings at $0.17 per share on revenue of $145.89 million. 
• Assured Guaranty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGO#NYSE">AGO</a>) is projected to report quarterly earnings at $1.36 per share on revenue of $201.37 million. 
• Stereotaxis (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/STXS#AMEX">STXS</a>) is likely to report quarterly loss at $0.05 per share on revenue of $7.10 million. 
• NET Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPWR#NYSE">NPWR</a>) is estimated to report quarterly loss at $0.09 per share on revenue of $3.00 million. 
• Luminar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) is expected to report quarterly loss at $0.17 per share on revenue of $18.68 million. 
• James River Gr Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JRVR#NASDAQ">JRVR</a>) is estimated to report quarterly earnings at $0.15 per share on revenue of $146.56 million. 
• Crescent Capital BDC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCAP#NASDAQ">CCAP</a>) is estimated to report quarterly earnings at $0.57 per share on revenue of $48.69 million. 
• IAC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAC#NASDAQ">IAC</a>) is estimated to report quarterly loss at $0.28 per share on revenue of $923.69 million. 
• Angi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGI#NASDAQ">ANGI</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $298.54 million. 
• Intevac (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVAC#NASDAQ">IVAC</a>) is expected to report quarterly loss at $0.15 per share on revenue of $11.50 million. 
• Nevro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVRO#NYSE">NVRO</a>) is likely to report quarterly loss at $0.81 per share on revenue of $93.07 million. 
• Zeta Global Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NYSE">ZETA</a>) is likely to report quarterly earnings at $0.17 per share on revenue of $248.65 million. 
• DoubleDown Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDI#NASDAQ">DDI</a>) is estimated to report quarterly earnings at $0.55 per share on revenue of $85.43 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ANGI

AROC

ASRT

ATER

BAER

BIOX

CCAP

GATO

GRAB

ISPR

IVAC

JRVR

LAZR

LINC

MLYS

NPWR

NUWE

NVRO

QUIK

STRW

STXS

TALO

TISI

XAIR

YALA

ZETA

Earnings Scheduled For November 11, 2024

Sapiens Intl Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPNS#NASDAQ">SPNS</a>) is preparing to release its quarterly earnings on Monday, 2024-11-11. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Sapiens Intl Corp to report an earnings per share (EPS) of $0.38.
The market awaits Sapiens Intl Corp's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Performance in Previous Earnings</h3>
The company's EPS beat by $0.01 in the last quarter, leading to a 1.16% drop in the share price on the following day.
Here's a look at Sapiens Intl Corp's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.36</td>
<td>0.34</td>
<td>0.34</td>
<td>0.34</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.37</td>
<td>0.36</td>
<td>0.36</td>
<td>0.34</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-1.0%</td>
<td>2.0%</td>
<td>1.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1731078104_0.png" alt="eps graph" />
<h3>Performance of Sapiens Intl Corp Shares</h3>
Shares of Sapiens Intl Corp were trading at $39.48 as of November 07. Over the last 52-week period, shares are up 56.05%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/SPNS/earnings">To track all earnings releases for Sapiens Intl Corp visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For Sapiens Intl Corp

ACIW

ADBE

ADEA

ADSK

AEYE

AGYS

AISP

AIXI

ALKT

ANSS

APPF

APPN

ARBK

ASAN

BILL

BLKB

BRZE

BTCM

BTCS

BTCT

CCSI

CIFR

CRWD

CVLT

CWAN

CYBR

DATS

DJCO

DOCU

DOMO

EGAN

EVCM

FICO

FTNT

GRYP

GTLB

HTCR

HUBS

IDAI

IDCC

INTA

INTU

IREN

KVYO

LMFA

MANH

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

MSTR

NCNO

ORCL

PANW

PCOR

PLTR

SDIG

SLNH

SNPS

SOUN

SPSC

SSTI

TENB

VRNS

WDAY

XTKG

Shares of software companies are trading higher in sympathy with overall market strength after Donald Trump was elected president of the United States.

Sapiens Intl Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPNS#NASDAQ">SPNS</a>) has outperformed the market over the past 15 years by 14.6% on an annualized basis producing an average annual return of 26.56%. Currently, Sapiens Intl Corp has a market capitalization of $2.00 billion. 
Buying $1000 In SPNS: If an investor had bought $1000 of SPNS stock 15 years ago, it would be worth $33,588.79 today based on a price of $35.94 for SPNS at the time of writing.
<h3>Sapiens Intl Corp's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1724335224_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Sapiens Intl Corp 15 Years Ago Would Be Worth Today

AILE

BLND

CDNS

CRNC

RBRK

WULF

Shares of companies in the software industry are trading higher amid overall tech sector momentum and in possibly sympathy with Cisco Systems which reported strong Q4 financial results.

Contracts

Sapiens Announces Sapiens ReinsurancePro Contract With Society Insurance; Terms Not Disclosed

Sapiens Announced That Continental General Insurance Company Has Selected It As A Technology Partner To Help Accelerate Operations, Modernize Its Platform For Future Insurance Products, And Enhance Its Ability To Scale In New Markets

Sapiens&#39; automation of the reinsurer&#39;s processes ensures financial stability and operational excellence

Sapiens ReinsurancePro Selected By Rockford Mutual Insurance To Enhance Efficiency And Mitigate Claims Leakage

Goldman Sachs analyst Kevin Kumar maintains Sapiens Intl Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPNS#NASDAQ">SPNS</a>) with a Buy and raises the price target from $38 to $43.

Goldman Sachs Maintains Buy on Sapiens Intl Corp, Raises Price Target to $43

Barclays analyst Tavy Rosner maintains Sapiens Intl Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPNS#NASDAQ">SPNS</a>) with a Underweight and raises the price target from $30 to $38.

Barclays Maintains Underweight on Sapiens Intl Corp, Raises Price Target to $38

Needham analyst Mayank Tandon maintains Sapiens Intl Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPNS#NASDAQ">SPNS</a>) with a Buy and raises the price target from $38 to $44.

Needham Maintains Buy on Sapiens Intl Corp, Raises Price Target to $44

William Blair analyst Dylan Becker reiterated a Hold rating on Sapiens (SPNS – Research Report) today. The company's shares opened today at $29.80....

William Blair Sticks to Its Hold Rating for Sapiens (SPNS)

Sapiens International Corporation N.V. (SPNS) Q3 2024 Earnings Call Transcript

Barclays analyst Tavy Rosner maintained a Sell rating on Sapiens (SPNS – Research Report) today and set a price target of $30.00. The company's sha...

Sapiens (SPNS) Gets a Sell from Barclays

Mayank Tandon, an analyst from Needham, maintained the Buy rating on Sapiens (SPNS – Research Report). The associated price target is $35.00. Mayan...

Buy Rating on Sapiens: Long-Term Strategy and Attractive Valuation Outweigh Short-Term Challenges

Barclays lowered the firm's price target on Sapiens (SPNS) to $30 from $38 and keeps an Underweight rating on the shares. The company's lower than ...

Sapiens price target lowered to $30 from $38 at Barclays

Sapiens (SPNS) has released an update. Sapiens International Corporation reported a 4.8% increase in revenue for Q3 2024, driven by growth in Europ...

Sapiens Reports Revenue Growth Amid Challenges

Sapiens (SPNS) has released an update. Sapiens International Corporation N.V. is set to hold its 2024 Annual General Meeting of Shareholders on Dec...

Sapiens Announces 2024 Annual Shareholders Meeting

Sapiens ( ($SPNS) ) has provided an announcement. Sapiens International Corporation's UnderwritingPro for Life & Annuities has been awarded the 202...

Sapiens Wins 2024 XCelent Award for Underwriting Innovation

Sapiens ( ($SPNS) ) has issued an update. Sapiens International Corporation has announced its participation in the 27th Annual Needham Growth Confe...

Sapiens to Attend 27th Annual Needham Growth Conference

The latest update is out from Sapiens ( ($SPNS) ). At its 2024 Annual General Meeting, Sapiens International Corporation N.V. successfully secured ...

Sapiens Secures Shareholder Approval for Key Proposals at 2024 AGM

Insurance

Press Releases

Sapiens Partners with Addresscloud to Enhance Insurers' Geographic Risk Insights

Tier-One Canadian Life and Health Insurance Carrier Selects Sapiens Insurance Platform to Foster Innovation, Drive Efficiency, and Improve Agent & Customer Experience

Sapiens Showcases Next-Gen Innovations at Annual North America Customer Summit in Austin, Texas

Hollard Group Risk Goes Live with Sapiens Data and Analytics Solution to Complement Sapiens CoreSuite for Life & Pensions

Sapiens Decision Launches Solution to Boost Decision Underwriting Efficiency and Profitability for P&C

SAPIENS TO ANNOUNCE THIRD QUARTER OF 2024 FINANCIAL RESULTS ON NOVEMBER 11, 2024

A Tier 1 Insurer in Africa Optimises Data Capabilities with Go-Live of Sapiens Data and Analytics Solution

Sapiens Reports Third Quarter 2024 Financial Results

Sapiens wins XCelent award for Customer Base and Support for UnderwritingPro for Life & Annuities

Sapiens to Participate in the 27th Annual Needham Growth Conference on January 15, 2025

Comments

Sapiens Intl Corp

Sapiens Intl Corp (SPNS) Opciones

Sapiens Intl Corp (NASDAQ:SPNS) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL